Health Information Technology Center for Education and Research on Therapeutics *

治疗学教育与研究健康信息技术中心*

• 批准号: 8265056
• 负责人: DAVID W., MD,Msc BATES
• 金额: $ 83.37万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-30 至 2016-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8265056
• 关键词: Health; Information; Technology; Center; Education

DESCRIPTION (provided by applicant): The proposed Health Information Technology Center for Education and Research on Therapeutics on Health Information Technology (HIT-CERT) will cover a range of issues relating to the impact of HIT on therapeutics, building both on the prior work of our CERT, as well as addressing important new areas. In particular, we will build on our work in leveraging HIT for pharmacosurveillance, medication reconciliation, and medication-related clinical decision support, and identify new ways to utilize information coming from medication-related decision support to advance our understanding of how providers are responding to it. We propose to carry out 4 research projects over a five-year period, each of which will address one or more of the programmatic interest areas identified in the CERT RFA, with our areas of focus being patient safety, development and enhancement of tools, health care system interventions, and translation into practice or policy. The four proposals will involve 1) leveraging new technologies to improve pharmacosurveillance; 2) making substantial improvements to an electronic medication reconciliation tool; 3) using new sources of data from clinical decision support to identify physician-level variation and use these results to improve safety and efficiency; and 4) directly improving medication-related clinical decision support In addition, the HIT-CERT will establish two cores that will support the 4 projects, and which will also enhance our ability to provide rapid response by our multidisciplinary team to requests by the AHRQ program staff and CERT steering committee. The cores will include a methodology/data resources core, and a translation/dissemination core. The proposed HIT-CERT will possess a number of important strengths': a strong and experienced investigator team with deep expertise in the areas of therapeutics and HIT and a long track record of collaborative activities; expertise across a wide range of disciplines, including medical informatics, medicine, nursing, pharmacy, pharmacoepidemiology, clinical epidemiology, biostatistics, health services research, health care policy, and educational theory and research; access to a broad range of electronic health record (EHR), e-prescribing, clinical decision support-related, and clinical data; and strong partnerships with key stakeholders at the national and regional level, to enable us to improve therapeutics in a variety of ways. We believe that this work will help in realizing some of the benefits from the large investment in HIT that the U.S is currently making. PUBLIC HEALTH RELEVANCE: The nation is adopting HIT and electronic prescribing at a rapid pace, and is at the same time faced with enormous challenges because of the high costs and suboptimal care quality. It is therefore imperative that we build our understanding of how HIT in general and electronic prescribing in particular work and do not work, and advance ways it can be leveraged most effectively to improve safety, quality, and efficiency. In particular, developing approaches that leverage medication-related decision support will be important.

描述（由申请人提供）：拟议的健康信息技术治疗教育和研究中心（HIT-CERT）将涵盖与 HIT 对治疗的影响相关的一系列问题，建立在我们的 CERT，以及解决重要的新领域。特别是，我们将在利用 HIT 进行药物监测、药物协调和药物相关临床决策支持方面的工作基础上，并确定利用来自药物相关决策支持的信息的新方法，以加深我们对提供者如何应对的理解它。我们建议在五年内开展 4 个研究项目，每个项目都将解决 CERT RFA 中确定的一个或多个计划兴趣领域，我们的重点领域是患者安全、工具的开发和增强、健康护理系统干预措施，并转化为实践或政策。这四项提案将涉及：1）利用新技术改善药物监测； 2) 对电子药物核对工具进行重大改进； 3）使用来自临床决策支持的新数据源来识别医生级别的差异，并利用这些结果来提高安全性和效率； 4) 直接改善药物相关的临床决策支持 此外，HIT-CERT 将建立两个核心来支持 4 个项目，这也将增强我们的多学科团队对 AHRQ 计划的要求做出快速响应的能力工作人员和 CERT 指导委员会。这些核心将包括方法/数据资源核心和翻译/传播核心。拟议的 HIT-CERT 将拥有许多重要优势： 强大且经验丰富的研究团队，在治疗和 HIT 领域拥有深厚的专业知识，并拥有长期的合作活动记录；跨学科的专业知识，包括医学信息学、医学、护理、药学、药物流行病学、临床流行病学、生物统计学、卫生服务研究、卫生保健政策以及教育理论和研究；访问广泛的电子健康记录 (EHR)、电子处方、临床决策支持相关数据和临床数据；与国家和区域层面的主要利益相关者建立强有力的伙伴关系，使我们能够以各种方式改进治疗。我们相信，这项工作将有助于实现美国目前对 HIT 的大量投资的一些好处。 公共健康相关性：国家正在快速采用 HIT 和电子处方，但同时由于高成本和次优的护理质量而面临着巨大的挑战。因此，我们必须了解一般的 HIT 和特定的电子处方如何发挥作用和不起作用，并推进如何最有效地利用它来提高安全性、质量和效率。特别是，开发利用药物相关决策支持的方法将非常重要。